Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Csernansky

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Brain Research. Developmental Brain Research|February 12, 1999
Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling ratsE M Montgomery, M E Bardgett, B Lall, et al.
Behavioral and Neural Biology|March 1, 1994
Chronic corticosterone treatment impairs spontaneous alternation behavior in ratsM E Bardgett, G T Taylor, J G Csernansky, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophreniaH A Whiteford, T J Stedman, J Welham, et al.
Psychiatry Research|August 1, 1990
Correlates of rapid neuroleptic response in male patients with schizophreniaE C Petrie, W O Faustman, J A Moses, et al.
Biological Psychiatry|December 4, 1998
Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia?J G Csernansky, C A Csernansky, L Kogelman, et al.
Neuroscience|July 31, 2004
Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stressH Dong, B Goico, M Martin, et al.
Life Sciences|January 1, 1993
Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivoH A Whiteford, M R Jarvis, T J Stedman, et al.
Psychopharmacology|October 29, 1997
The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapineM E Bardgett, S L Salaris, J L Jackson, et al.
Archives of General Psychiatry|July 1, 1988
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptomsJ G Csernansky, S J Riney, L Lombrozo, et al.
Neurology|June 1, 1996
CSF excitatory amino acids and severity of illness in Alzheimer's diseaseJ G Csernansky, M E Bardgett, Y I Sheline, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Brain Research. Developmental Brain Research|February 12, 1999
Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling ratsE M Montgomery, M E Bardgett, B Lall, et al.
Behavioral and Neural Biology|March 1, 1994
Chronic corticosterone treatment impairs spontaneous alternation behavior in ratsM E Bardgett, G T Taylor, J G Csernansky, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophreniaH A Whiteford, T J Stedman, J Welham, et al.
Psychiatry Research|August 1, 1990
Correlates of rapid neuroleptic response in male patients with schizophreniaE C Petrie, W O Faustman, J A Moses, et al.
Biological Psychiatry|December 4, 1998
Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia?J G Csernansky, C A Csernansky, L Kogelman, et al.
Neuroscience|July 31, 2004
Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stressH Dong, B Goico, M Martin, et al.
Life Sciences|January 1, 1993
Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivoH A Whiteford, M R Jarvis, T J Stedman, et al.
Psychopharmacology|October 29, 1997
The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapineM E Bardgett, S L Salaris, J L Jackson, et al.
Archives of General Psychiatry|July 1, 1988
Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptomsJ G Csernansky, S J Riney, L Lombrozo, et al.
Neurology|June 1, 1996
CSF excitatory amino acids and severity of illness in Alzheimer's diseaseJ G Csernansky, M E Bardgett, Y I Sheline, et al.
Pageof 14